Well said, I would only disagree with the treatment of Gilead and pharma in general. The moral outrage is against greed. Even when the cost-benefit relation wor

Well said, I would only disagree with the treatment of Gilead and pharma in general. The moral outrage is against greed. Even when the cost-benefit relation works to other (similarly overpriced) treatments, their margins are way too excessive from the patients' pov imo, because 1. manufacturing cost next to nothing 2. pharma spends way more on marketing than r&d [1] [1] http://www.randalolson.com/2015/03/01/design-critique-putting-big-pharma-spending-in-perspective/ http://www.randalolson.com/2015/03/01/design-critique-puttin...